Download
Download by
Scanning QR Code
  • Download app

    Download app

  • Online Inquiry

    Log in to access Online Inquiry
+
Congratulations
You've successfully got advanced quotes worth 5000 HKD
Download APP >>
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Futubull > Quotes > HLVX HilleVax > Detailed Quotes

HLVX HilleVax

Watchlist
15.140
-1.160-7.12%
Close  12/09 16:00 ET
15.1400.0000.00%
Post Mkt Price 12/09 16:01 ET
High
16.110
Open
16.060
Turnover
635.68K
Low
15.050
Pre Close
16.300
Volume
41.09K
Market Cap
504.85M
P/E(TTM)
Loss
52wk High
24.420
Shares
33.35M
P/E(Static)
Loss
52wk Low
7.900
Float Cap
80.26M
Bid/Ask %
0.00%
Historical High
24.420
Shs Float
5.30M
Volume Ratio
0.62
Historical Low
7.900
Dividend TTM
--
Div Yield TTM
--
P/B
1.76
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.78%
Amplitude
6.50%
Avg Price
15.468
Lot Size
1
Float Cap
80.26M
Bid/Ask %
0.00%
Historical High
24.420
Shs Float
5.30M
Volume Ratio
0.62
Historical Low
7.900
Dividend TTM
--
P/B
1.76
Dividend LFY
--
Turnover Ratio
0.78%
Amplitude
6.50%
Avg Price
15.468
Lot Size
1
Price Forecast

News

Comment

Company Overview More
HilleVax, Inc. operates as a clinical-stage biopharmaceutical company focused on developing and commercializing novel vaccines. Its initial program, HIL-214, is a virus-like particle (VLP) based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection. The company was founded by Dr. Maurice Hilleman and Dr. Tadataka Yamada on 3rd March, 2020 and is headquartered in Boston, MA.
CEO: Dr. Robert M. Hershberg, M.D.,PhD
Market: NASDAQ
Listing Date: 04/29/2022
Futu Hot List
USHKCN
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist